Radhakrishnan P. Iyer is Chief Scientific Officer at F-star Therapeutics, Inc. (SBPH). They have made 1 open-market trade across 1 company since 2020, most recently 2020-11-20.
CIK 0001664423
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SBPH | 125,137 | $606K |
Shares reported on the most recent Form 4, priced at the 2020-11-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SBPH | SELL | 2020-11-20 | 2020-11-23 | $4.76 | $833 | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.